X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Multiple Myeloma Companies

This report lists the top Multiple Myeloma companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Multiple Myeloma industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Multiple Myeloma Top Companies

  1. Bristol-Myers Squibb

  2. Takeda Pharmaceuticals

  3. Amgen

  4. Sanofi

  5. Karyopharm Therapeutics

*Disclaimer: Top companies sorted in no particular order

Multiple Myeloma Market Major Players

Multiple Myeloma Market Concentration

Multiple Myeloma  Market Concentration

Multiple Myeloma Company List

                            • Bristol-Myers Squibb Company

                            • Takeda Pharmaceutical Company Limited

                            • Amgen Inc.

                            • Sanofi S.A.

                            • Karyopharm Therapeutics Inc.

                            • Ono Pharmaceutical Co., Ltd.

                            • Novartis International AG

                            • Teva Pharmaceutical Industries Ltd.

                            • Johnson and Johson, Inc. (Janssen Pharmaceuticals)

                            • AbbVie Inc.

                            • GlaxoSmithKline plc

                            • Harpoon Therapeutics


                        Specific to Multiple Myeloma Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Multiple Myeloma Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)